Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

WCM/EADO 2021 | Impact and role of radiotherapy in the management of MCC

Name: Impact and role of radiotherapy in the management of MCC
Uploaded: 2021-04-14T00:00:00Z
Duration: 3 min 43 s

Paul Nghiem • 14 Apr 2021

WCM/EADO 2021

Merkel Cell Carcinoma Skin Cancer

Paul Nghiem, MD, PhD, University of Washington, Seattle, WA, gives an overview of the early management of merkel cell carcinoma (MCC), higlighting the importance of a baseline PET scan. Prof. Ngheim reports that one in six patients with MCC will have an upstaging with a baseline PET scan. FInally, Prof. Ngheim discusses challenges around the integration of radiotherapy and surgery. This interview took place during the 10th World Congress of Melanoma in conjunction with the 17th EADO Congress Interactive Virtual Meeting.

Disclosures

Paul Nghiem, MD, PhD, has served on an advisory board for EMD Serono and Pfizer and has received institutional research funding to institution from Bristol Myers Squibb and EMD Serono.